SEGMENT INFORMATION (Tables)

3 Months Ended

Oct. 31, 2013

The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes, for the three months ended October 31, 2013 and October 31, 2012.



	Three Months Ended
	Oct 31, 2013		Oct 31, 2012
SALES:
Life Sciences	$	318,946	$	299,951
Industrial	310,833		327,649
Total	$	629,779	$	627,600
SEGMENT PROFIT:
Life Sciences	$	73,045	$	69,842
Industrial	50,482		52,766
Total segment profit	123,527		122,608
Corporate Services Group	15,964		14,065
ROTC	9,198		4,274
Interest (income)/expense, net	5,977		(568		)
Earnings from continuing operations before income taxes	$	92,388	$	104,837

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details